Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

(2021) Dionne M. Hines et al.   HEADACHE

Pathophysiological Bases of Comorbidity in Migraine

(2021) Claudia Altamura et al.   Frontiers in Human Neuroscience

Migraine: epidemiology and systems of care

(2021) Messoud Ashina et al.   LANCET

Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019

(2021) Saeid Safiri et al.   PAIN

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

(2021) Jessica Ailani et al.   HEADACHE

Comorbidities of primary headache disorders: a literature review with meta-analysis

(2021) Valeria Caponnetto et al.   JOURNAL OF HEADACHE AND PAIN

Diagnosis and management of migraine in ten steps

(2021) Anna K. Eigenbrodt et al.   Nature Reviews Neurology

What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics

(2021) F. Radat   REVUE NEUROLOGIQUE

United States Patients’ Perspective of Living With Migraine: Country‐Specific Results From the Global “My Migraine Voice” Survey

(2020) Sarah N. Gibbs et al.   HEADACHE

Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?

(2020) David Moreno-Ajona et al.   CURRENT OPINION IN NEUROLOGY

Teaching Video Neuroimages: Spontaneous nystagmus reversal in acute attack of ménière’s disease

(2020) Anand K. Bery et al.   NEUROLOGY

Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019

(2020) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies

(2019) Andrea Negro et al.   Expert Review of Neurotherapeutics

The American Headache Society’s Position Statement on Integrating New Migraine Treatments into Clinical Practice – Comments

(2019) James A. Charles et al.   HEADACHE

Migraine

(2019) Rebecca C. Burch et al.   NEUROLOGIC CLINICS

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis

(2016) Zsolt Hepp et al.   CEPHALALGIA

Systematic Review of Migraine Prophylaxis Adherence and Persistence

(2016) Zsolt Hepp et al.   JOURNAL OF MANAGED CARE PHARMACY

The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

(2015) Michael J. Marmura et al.   HEADACHE

Adherence to oral migraine-preventive medications among patients with chronic migraine

(2014) Zsolt Hepp et al.   CEPHALALGIA

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)

(2013) Andrew M. Blumenfeld et al.   HEADACHE

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1

(2012) S.D. Silberstein et al.   NEUROLOGY